Accelerating Discovery
From comprehensive Antibody Characterization to AI-driven Multi-Omics integration. We provide the high-resolution data you need to drive therapeutic breakthroughs.
Antibody Characterization
Comprehensive structural and PTM analysis of biopharmaceutical antibodies, with peptide mapping as a core capability to support sequence confirmation, comparability, and stability assessment.
Core Services
Mass Spectrometry Solutions
Advanced LC–MS workflows spanning proteomics, targeted bioanalysis, and multi-omics, designed to support discovery, translational and clinical research.
AI Multi-Omics Analysis
Integrated analysis of complex biological datasets using interpretable, data-driven computational frameworks to support hypothesis generation and decision-making.
Why OmicSkyBio
One scientific owner
One integrated data set
One decision
-
Problem-driven analytics, scientific strategy and method selection aligned to your question
-
Fit-for-purpose study design aligned with project objectives
-
High data quality and interpretability
-
​Advanced MS data processing and cross-study harmonization
-
Flexible CRO engagement model, tailored to each study
-
Each project is designed to deliver actionable insights
Our Hybrid Model
Scientific Owner
-
Study design
-
Method selection
-
Interpretation
CRO Network
-
Execution capacity
-
Specialty assays
-
Logistics
Decision-Ready Deliverables
-
Tables+ figures
-
Clear summary
-
Review call
Who We Support?
Supporting biotech and pharmaceutical R&D teams across discovery and development.
